CLAFORAN - PWS INJ 2.0G/VIAL POWDER FOR SOLUTION

Страна: Канада

Език: английски

Източник: Health Canada

Купи го сега

Активна съставка:

CEFOTAXIME SODIUM

Предлага се от:

SANOFI-AVENTIS CANADA INC

АТС код:

J01DD01

INN (Международно Name):

CEFOTAXIME

дозиране:

2G

Лекарствена форма:

POWDER FOR SOLUTION

Композиция:

CEFOTAXIME SODIUM 2G

Начин на приложение:

INTRAMUSCULAR

Броя в опаковка:

IM:6ML/IV:11ML/IV INF.:56ML TO 1011ML; 10X2G

Вид предписание :

Prescription

Терапевтична област:

THIRD GENERATION CEPHALOSPORINS

Каталог на резюме:

Active ingredient group (AIG) number: 0152507002; AHFS:

Статус Оторизация:

CANCELLED POST MARKET

Дата Оторизация:

2017-11-24

Данни за продукта

                                PRODUCT MONOGRAPH
PR
CLAFORAN
®
Cefotaxime for injection, Mfr. Std.
1g and 2g cefotaxime (as cefotaxime sodium) per vial
β-lactam Antibiotic
sanofi-aventis Canada Inc.
2905 Place Louis-R-Renaud
Laval, Quebec H7V 0A3
Date of Revision:
November 12, 2014
Submission Control No.: 176886
s-a Version dated
2
PRODUCT MONOGRAPH
PR
CLAFORAN
®
Cefotaxime for injection, Mfr. Std.
1g and 2g cefotaxime (as cefotaxime sodium) per vial
β-lactam Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
CLAFORAN (cefotaxime for injection) is a semi-synthetic,
2-aminothiazolyl cephalosporin
antibiotic for parenteral use. _In vitro _studies indicate that the
antibacterial action of CLAFORAN
results from inhibition of cell wall synthesis. It is stable against
the action of most β-lactamases.
INDICATIONS AND CLINICAL USE
TREATMENT
_ _
_ _
CLAFORAN (cefotaxime for injection) may be indicated for the treatment
of infections caused
by susceptible strains of the designated micro-organisms in the
diseases listed below.
LOWER RESPIRATORY TRACT INFECTIONS:
Pneumonia
and
lung
abscess
caused
by
_Streptococcus _
_pneumoniae_
(formerly
_Diplococcus_
_pneumoniae_), other streptococci (excluding enterococci, e.g. _S.
faecalis_),_ Staphylococcus_ _aureus_
(penicillinase
and
non-penicillinase
producing),_ _
_Escherichia _
_coli_,_ _
_Hemophilus _
_influenzae_,
(including ampicillin resistant strains) and unspecified _Klebsiella_
species.
URINARY TRACT INFECTIONS:
Caused by _Escherichia coli_, unspecified _Klebsiella_ species
(including _K. pneumoniae_),_ Proteus_
_mirabilis_, indole positive _ Proteus_, _ Serratia marcescens_ and _
Staphylococcus epidermidis_. Also,
uncomplicated gonorrhea caused by _N. gonorrhoeae_ including
penicillin resistant strains.
BACTEREMIA/SEPTICEMIA:
Caused by _Escherichia coli_, unspecified _Klebsiella_ strains and
_Serratia marcescens_.
SKIN INFECTIONS:
Caused
by
_Staphylococcus _
_aureus_
(penicillinase
and
non-penicillinase
producing),
_S. epidermidis_, group A streptococci, _ Escherichia coli_, _ Proteus
mirabilis_ and indole
                                
                                Прочетете целия документ
                                
                            

Документи на други езици

Данни за продукта Данни за продукта френски 12-11-2014

Сигнали за търсене, свързани с този продукт

Преглед на историята на документите